US00653Q1022
US00653Q1022
AdaptHealth Corp.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 824.49M EUR | 1.39B EUR | 1.58B EUR | 1.32B EUR |
Enterprise Value | 2.84B EUR | 3.41B EUR | 3.54B EUR | 3.12B EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | -48.87x | -- | -- | -- |
Price to Sales | 0.25x | 0.43x | 0.5x | 0.51x |
Price to Book | 0.59x | 1.01x | 1.05x | 0.87x |
EV/Revenue | 0.84x | 1.05x | 1.11x | 1.21x |
EV/EBITDA | 4.87x | 6.45x | 6.62x | 7.38x |
Price to FCF (P/FCF) | -- | 14.23x | 8.25x | 6.01x |
EV/FCF | -- | 34.93x | 18.42x | 14.2x |
FCF Yield | -9.79% | 7.03% | 12.12% | 16.63% |